Despite the increase, Infamed points to a slowdown in spending in the first seven months of the year. Oncology and HIV therapy with higher expense weight.
Local health units (ULS) and oncology institutes spent about €1,600 million on medicines in the first seven months of the year, more than €70 million than in the same period of 2025.